, , vol.86, pp.3-132
,
,
,
,
,
,
, Constitution des lipoprotéines selon l'évolution dans le groupe IC, Tableau, vol.12
, Parmi les IC, le taux de PCSK9 était plus bas dans le groupe évoluant favorablement mais de
Heart Disease and Stroke Statistics-2017 Update, vol.135, pp.146-603, 2017. ,
La prévention et la prise en charge des accidents vasculaires cérébraux en France: synthèse du rapport à Madame la ministre de la santé et des sports, 2018. ,
L'accident vasculaire cérébral en France : patients hospitalisés pour AVC en, Bull Epidémiol Hebd, vol.21, issue.5, pp.84-94, 2008. ,
Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy, Neurotherapeutics, vol.8, issue.3, pp.319-348, 2011. ,
Les apports du registre dijonnais des accidents vasculaires cérébraux en 20 ans d'activité, Rev Neurol, vol.164, issue.2, pp.138-147, 2008. ,
Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database, Arch Cardiovasc Dis, vol.109, issue.6-7, pp.399-411, 2016. ,
, Prévention vasculaire après un infarctus cérébral ou un accident ischémique transitoire
National Trends in Patients Hospitalized for Stroke and Stroke Mortality in France, vol.48, pp.2939-2984, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-01647587
Distinguishing between stroke and mimic at the bedside: the brain attack study, Stroke, vol.37, issue.3, pp.769-75, 2006. ,
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, N Engl J Med, vol.359, issue.13, pp.1317-1346, 2008. ,
Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions, Cerebrovasc Dis Basel Switz, vol.34, issue.2, pp.106-120, 2012. ,
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. The Lancet, vol.376, pp.112-135, 2010. ,
, Conseil Economique Social et Environnemental Régional
, Diabète et santé publique à la Réunion : comment transformer un cercle vicieux en un cercle vertueux
Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes, Stroke, vol.27, issue.1, pp.63-71, 1996. ,
Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care, Ann Intern Med, vol.138, issue.7, pp.593-602, 2003. ,
Prevalence of Type 2 diabetes and central adiposity in La Reunion Island, the REDIA Study, Diabetes Res Clin Pract, vol.67, issue.3, pp.234-276, 2005. ,
The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women, J Am Coll Cardiol, vol.48, issue.11, pp.2235-2277, 2006. ,
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, vol.45, issue.7, pp.2160-236, 2014. ,
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths, Lancet Lond Engl, vol.370, issue.9602, pp.1829-1868, 2007. ,
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study, Lancet Lond Engl, vol.372, issue.9634, pp.224-257, 2008. ,
High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study, JAMA, vol.285, issue.21, pp.2729-2764, 2001. ,
Major lipids, apolipoproteins, and risk of vascular disease, JAMA, vol.302, issue.18, pp.1993-2000, 2009. ,
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease, J Intern Med, vol.259, issue.5, pp.455-61, 2006. ,
Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS), J Intern Med, vol.265, issue.2, pp.275-87, 2009. ,
Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study, J Intern Med, vol.259, issue.3, pp.259-66, 2006. ,
Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack, Cerebrovasc Dis Basel Switz, vol.21, issue.5-6, pp.323-331, 2006. ,
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial, N Engl J Med, vol.320, issue.14, pp.904-914, 1989. ,
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region, Int J Epidemiol, vol.32, issue.4, pp.563-72, 2003. ,
Risk factors for intracerebral hemorrhage in a pooled prospective study, Stroke, vol.38, issue.10, pp.2718-2743, 2007. ,
, The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-Dose Atorvastatin after Stroke or Transient Ischemic Attack, N Engl J Med, vol.355, issue.6, pp.549-59, 2006.
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia, N Engl J Med, vol.356, issue.16, pp.1620-1650, 2007. ,
Effects of dalcetrapib in patients with a recent acute coronary syndrome, N Engl J Med, vol.367, issue.22, pp.2089-99, 2012. ,
Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial, Eur Heart J, vol.33, issue.7, pp.857-65, 2012. ,
Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis, Pathophysiol Off J Int Soc Pathophysiol, vol.17, issue.3, pp.197-218, 2010. ,
Pathobiology of injury after stroke: the neurovascular unit and beyond, Ann N Y Acad Sci, vol.1268, pp.21-26, 2012. ,
Viability thresholds and the penumbra of focal ischemia, Ann Neurol, vol.36, issue.4, pp.557-65, 1994. ,
Excitotoxicity and stroke: Identifying novel targets for neuroprotection, Prog Neurobiol, vol.115, pp.157-88, 2014. ,
Apoptotic and Necrotic Death Mechanisms Are Concomitantly Activated in the Same Cell After Cerebral Ischemia, Stroke, vol.35, issue.9, pp.2189-94, 2004. ,
Pathobiology of ischaemic stroke: an integrated view, Trends Neurosci, vol.22, issue.9, pp.391-398, 1999. ,
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells, J Leukoc Biol, vol.87, issue.5, pp.779-89, 2010. ,
Inflammatory Cell Infiltration after Endothelin-1-Induced Cerebral Ischemia: Histochemical and Myeloperoxidase Correlation with Temporal Changes in Brain Injury, J Cereb Blood Flow Metab, vol.27, issue.1, pp.100-114, 2007. ,
Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage, Stroke, vol.27, issue.10, pp.1739-1782, 1996. ,
Reactive oxygen species and ischemic cerebrovascular disease, Neurochem Int, vol.60, issue.2, pp.208-220, 2012. ,
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the, American Heart Association/American Stroke Association. Stroke, vol.49, issue.3, pp.46-99, 2018. ,
Endovascular thrombectomy beyond 12 hours of stroke onset: a stroke network's experience of late intervention, J Neurointerventional Surg, vol.10, issue.11, pp.1043-1049, 2018. ,
ASPECTS CT in Acute Ischemia: Review of Current Data. Top Magn Reson Imaging TMRI, vol.26, pp.103-115, 2017. ,
, Place de l'imagerie dans la prise en charge de l'AVC, 2019.
Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set, Stroke, vol.42, issue.5, pp.1270-1275, 2011. ,
Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics, Stroke, vol.34, issue.4, pp.932-939, 2003. ,
Diffusion MRI in patients with transient ischemic attacks, Stroke, vol.30, issue.6, pp.1174-80, 1999. ,
Clinical and diffusion-weighted imaging characteristics of an identifiable subset of TIA patients with acute infarction, Stroke, vol.30, p.235, 1999. ,
Transient ischemic attack--proposal for a new definition, N Engl J Med, vol.347, issue.21, pp.1713-1719, 2002. ,
Clinical Mimics: An Emergency Medicine-Focused Review of Stroke Mimics, J Emerg Med, vol.52, issue.2, pp.176-83, 2017. ,
Stroke care units versus general medical wards for acute management of stroke in Japan, Stroke, vol.44, issue.11, pp.3142-3149, 2013. ,
Stroke Units Versus General Medical Wards, I: Twelve-and Eighteen-Month Survival: A Randomized, Controlled Trial. Stroke, vol.29, pp.58-62, 1998. ,
Volumétrie de l'ischémie cérébrale en IRM de diffusion et déficit fonctionnel secondaire après thrombolyse intraveineuse, Journal of Neuroradiology, vol.39, issue.2, pp.97-103, 2012. ,
Which targets are relevant for therapy of acute ischemic stroke? Stroke, vol.30, pp.1486-1495, 1999. ,
, Tissue Plasminogen Activator for Acute Ischemic Stroke, N Engl J Med, vol.333, issue.24, pp.1581-1589, 1995.
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS), JAMA J Am Med Assoc, vol.274, issue.13, pp.1017-1042, 1995. ,
Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA), J Clin Pharm Ther, vol.37, issue.6, pp.620-629, 2012. ,
Marked Regional Variation in Acute Stroke Treatment Among Medicare Beneficiaries, Stroke, vol.46, issue.7, pp.1890-1896, 2015. ,
, Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better? BMC Neurology, vol.16, p.53, 2016.
Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided, Cerebrovasc Dis Basel Switz, vol.23, issue.4, pp.294-302, 2007. ,
Proportion of patients treated with thrombolysis in a centralized versus a decentralized acute stroke care setting, Stroke, vol.43, issue.5, pp.1336-1376, 2012. ,
Impact du plan AVC sur la prise en charge des accidents vacsulaires cérébraux ischémiques contitués : évolution 2011-2016 des indicateurs d'évaluation de la Haute Autorité de Santé, 2018. ,
Endovascular Treatment for Acute Ischemic Stroke, N Engl J Med, vol.368, issue.10, pp.904-917, 2013. ,
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke, N Engl J Med, vol.372, issue.1, pp.11-20, 2015. ,
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke, N Engl J Med, vol.372, issue.11, pp.1019-1049, 2015. ,
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke, N Engl J Med, vol.372, issue.24, pp.2285-95, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02007226
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection, N Engl J Med, vol.372, issue.11, pp.1009-1027, 2015. ,
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke, N Engl J Med, vol.372, issue.24, pp.2296-306, 2015. ,
Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial, Lancet Neurol, vol.15, issue.11, pp.1138-1185, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01825521
Prévention vasculaire après un infarctus cérébral ou un accident ischémique transitoire, J Mal Vasc, vol.33, p.71, 2008. ,
Plasma lipoproteins: apolipoprotein structure and function, J Lipid Res, vol.25, issue.12, pp.1277-94, 1984. ,
Peptide composition of human plasma apolipoproteins A, B and C, Expos Annu Biochim Med, vol.31, pp.145-60, 1972. ,
ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins, Curr Opin Lipidol, vol.11, issue.3, pp.253-60, 2000. ,
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI, Nature, vol.353, issue.6341, pp.265-272, 1991. ,
Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor, Arterioscler Thromb Vasc Biol, vol.23, issue.10, pp.1914-1934, 2003. ,
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family, J Clin Invest, vol.66, issue.5, pp.892-900, 1980. ,
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, JAMA, vol.290, issue.17, pp.2292-300, 2003. ,
Apolipoprotein A-II, HDL metabolism and atherosclerosis, Atherosclerosis, vol.164, issue.1, pp.1-13, 2002. ,
Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity, J Lipid Res, 2019. ,
Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes, Biochimie, vol.96, pp.56-66, 2014. ,
High-density lipoprotein subfractions: current views and clinical practice applications, Trends Endocrinol Metab TEM, vol.25, issue.7, pp.329-365, 2014. ,
Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma, Circulation, vol.128, issue.15, pp.1644-55, 2013. ,
Differential effects of HDL subpopulations on cellular ABCA1-and SR-BI-mediated cholesterol efflux, J Lipid Res, vol.46, issue.10, pp.2246-53, 2005. ,
Dysfunctional HDL in acute stroke, Atherosclerosis, vol.253, pp.75-80, 2016. ,
Paraoxonase and atherosclerosisrelated cardiovascular diseases, Biochimie, vol.132, pp.19-27, 2017. ,
Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT, Biochim Biophys Acta, vol.1821, issue.3, pp.416-440, 2012. ,
Compromised LCAT function is associated with increased atherosclerosis, Circulation, vol.112, issue.6, pp.879-84, 2005. ,
Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis, Metabolism, vol.83, pp.245-55, 2018. ,
Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up, Atherosclerosis, vol.177, issue.2, pp.361-367, 2004. ,
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?, J Lipid Res, vol.53, issue.9, pp.1783-99, 2012. ,
Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo, Circulation, vol.120, issue.2, pp.160-169, 2009. ,
Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair, Trends Cardiovasc Med, vol.17, issue.5, pp.156-61, 2007. ,
HDL and endothelial protection, Br J Pharmacol, vol.169, issue.3, pp.493-511, 2013. ,
Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I, J Cell Mol Med, vol.14, issue.3, pp.608-628, 2010. ,
Platelet activation by plasma lipoproteins, Prog Cardiovasc Dis, vol.30, issue.1, pp.61-72, 1987. ,
Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis, Pharmacol Rev, vol.58, issue.3, pp.342-74, 2006. ,
Antiinflammatory properties of HDL, Circ Res, vol.95, issue.8, pp.764-72, 2004. ,
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits, Circulation, vol.111, issue.12, pp.1543-50, 2005. ,
High-density lipoprotein: antioxidant and anti-inflammatory properties, Curr Atheroscler Rep, vol.9, issue.3, pp.244-252, 2007. ,
Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress, Arterioscler Thromb Vasc Biol, vol.23, issue.10, pp.1881-1889, 2003. ,
Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: role of glutamate and its transporters, Anesthesiology, vol.99, issue.2, pp.368-75, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00306843
Neuroprotection for ischemic stroke: past, present and future, Neuropharmacology, vol.55, issue.3, pp.363-89, 2008. ,
High-density lipoprotein heterogeneity and function in reverse cholesterol transport, Curr Opin Lipidol, vol.21, issue.3, pp.229-267, 2010. ,
An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association, Stroke, vol.44, issue.7, pp.2064-89, 2013. ,
, Moins de naissances et plus de décès -Bilan démographique 2016 à la Réunion
Diabetes, hyperglycaemia, and acute ischaemic stroke, Lancet Neurol, vol.11, issue.3, pp.261-71, 2012. ,
Cardioembolic stroke: an update, South Med J, vol.96, issue.4, pp.343-352, 2003. ,
Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria: Incidence, Recurrence, and Long-Term Survival in Ischemic Stroke Subtypes: A Population-Based Study, Stroke, vol.32, issue.12, pp.2735-2775, 2001. ,
Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis, Stroke, vol.46, issue.5, pp.1281-1288, 2015. ,
Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial, Stroke, vol.40, issue.7, pp.2486-92, 2009. ,
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events, N Engl J Med, vol.357, issue.13, pp.1301-1311, 2007. ,
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review, Atherosclerosis, vol.196, issue.2, pp.489-96, 2008. ,
Associations between highdensity lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region, Eur Heart J, vol.28, issue.21, pp.2653-60, 2007. ,
Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study, Stroke, vol.34, issue.3, pp.623-654, 2003. ,
Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe, J Epidemiol Community Health, vol.56, issue.1, pp.19-24, 2002. ,
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial, Lancet Lond Engl, vol.376, issue.9738, pp.333-342, 2010. ,
Biological activities of HDL subpopulations and their relevance to cardiovascular disease, Trends Mol Med, vol.17, issue.10, pp.594-603, 2011. ,
LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality, Atherosclerosis, vol.210, issue.2, pp.548-54, 2010. ,
Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women, Stroke, vol.43, issue.4, pp.958-66, 2012. ,
Protective effect of high-density lipoprotein-based therapy in a model of embolic stroke, Stroke, vol.41, issue.7, pp.1536-1578, 2010. ,
Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients, Atherosclerosis, issue.1, pp.192-200, 2015. ,
Association of serum lipids with clinical outcome in acute ischaemic stroke: A systematic review and meta-analysis, J Clin Neurosci Off J Neurosurg Soc Australas, vol.59, pp.236-280, 2019. ,
Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study, Atherosclerosis, vol.228, issue.2, pp.472-479, 2013. ,
The Short-term Prognostic Value of the Triglyceride-to-high-density Lipoprotein Cholesterol Ratio in Acute Ischemic Stroke, Aging Dis, vol.9, issue.3, pp.498-506, 2018. ,
Triglyceride to high-density lipoprotein cholesterol ratio predicts worse outcomes after acute ischaemic stroke, Eur J Neurol, vol.24, issue.2, pp.283-91, 2017. ,
The total cholesterol to high-density lipoprotein cholesterol as a predictor of poor outcomes in a Chinese population with acute ischaemic stroke, J Clin Lab Anal, issue.6, p.31, 2017. ,
Elevated C-reactive Protein and Depressed High-density Lipoprotein Cholesterol are Associated with Poor Function Outcome After Ischemic Stroke, Curr Neurovasc Res, vol.15, issue.3, pp.226-259, 2018. ,
Early predictors of death and disability after acute cerebral ischemic event, Stroke, vol.26, issue.3, pp.392-400, 1995. ,
Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke, Neurology, vol.59, issue.1, pp.67-71, 2002. ,
Admission Body Temperature Predicts Long-Term Mortality After Acute Stroke: The Copenhagen Stroke Study, Stroke, vol.33, issue.7, pp.1759-62, 2002. ,
Prediction of Malignant Middle Cerebral Artery Infarction by Diffusion-Weighted Imaging, Stroke, vol.31, issue.9, pp.2175-81, 2000. ,
Early Arterial Study in the Prediction of Mortality After Acute Ischemic Stroke, Stroke, vol.38, issue.7, pp.2085-2094, 2007. ,
Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST), Neurology, vol.53, issue.1, pp.126-157, 1999. ,
Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial, Neurology, vol.55, issue.7, pp.952-961, 2000. ,
Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale, Stroke, vol.33, issue.9, pp.2243-2249, 2002. ,
Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview, Stroke, vol.36, issue.4, pp.777-81, 2005. ,
What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2?, J Neurol, vol.255, issue.6, pp.867-74, 2008. ,
Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD, Am J Kidney Dis, issue.18, pp.31158-31160, 2019. ,
A study of serum apolipoprotein A1, apolipoprotein B and lipid profile in stroke, J Clin Diagn Res JCDR, vol.7, issue.7, pp.1303-1309, 2013. ,
The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes, Diabetologia, vol.49, issue.8, pp.1946-54, 2006. ,
Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels, Circ Res, vol.92, issue.9, pp.969-75, 2003. ,
Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila, Proc Natl Acad Sci, vol.105, issue.19, pp.7088-93, 2008. ,
Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress, Aging Cell, vol.7, issue.4, pp.506-521, 2008. ,
The plant Apolipoprotein D ortholog protects Arabidopsis against oxidative stress, BMC Plant Biol, vol.8, p.86, 2008. ,
Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice, Mol Neurobiol, vol.54, issue.6, pp.3948-63, 2017. ,
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease, N Engl J Med, vol.354, issue.12, pp.1264-72, 2006. ,
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials, J Endocrinol Invest, pp.1-11, 2019. ,
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease, N Engl J Med, vol.376, issue.18, pp.1713-1735, 201704. ,
URL : https://hal.archives-ouvertes.fr/hal-01896445